semaglutide 15 mg Premium Peptide | GLP-1 Agonist Semaglutide | Clinician-Reviewed Peptide Therapy

There is an ever-growing list of established indications for GLP-1 based medications

Its not a trendits a transformation

Compared to the non-semaglutide cohort, the semaglutide cohort had an elevated risk of NAION, with a hazard ratio of 7.64

That doesn't bother me." She sees GLP-1 medications as valuable additions to surgical options: "Bariatric surgery is still the number one treatment that we have with studies and stuff

However, in March 2025, Federal Health Minister Mark Butler wrote to the PBAC to seek their expert advice on equitable access to obesity medicines through the PBS, recognising the potential benefits but also the significant cost to the healthcare system of subsidising these medicines, the spokesperson told newsGP